Comparison of Two Intermittent Urinary Catheters
Study Details
Study Description
Brief Summary
This is an unblinded, multi-center, randomized, controlled, cross-over study assessing wheel-chair bound, male user preference and catheter characteristics of two intermittent urinary catheters. Subjects enrolled in the study will be randomized to order of catheter use. Individual participation will consist of approximately 1 week of product use. The null hypothesis to be tested is there no difference between catheters.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
-
is male and at least 18 years of age.
-
is self-catheterizing at least 3 times a day.
-
has been performing catheterizations for at least 2 months.
-
is wheelchair bound.
-
is able to use a size 12 or 14 French straight catheter.
-
is willing and able to follow the study protocol and Investigator's instructions.
-
is in the opinion of the Investigator, qualified to participate.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: 30 cm Intermittent Catheter Intervention was the test of a 30 cm catheter compared to standard commercial 40 cm catheter in a cross-over design. |
Device: 30 cm Intermittent Catheter
Randomized cross-over
Other Names:
|
Active Comparator: 40 cm Intermittent Catheter Active comparator 40 cm commercial catheter was compared to experimental 30 cm catheter in a cross-over design. |
Device: 40 cm Intermittent Catheter
randomized cross-over
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Percentage of Participants [1 week]
Percentage of participants that preferred the 40 cm catheter
Secondary Outcome Measures
- Assessment of Ease of Use Characteristics [1 week]
Ease of insertion, removal, and control while catheterizing were assessed using a 5 point Likert scale. The numbers recorded are the percentage of the "top" two responses on a 5 point Likert scale. On one scale this includes 1) Very Easy or 2) Easy, on a scale ranging from 1) Very Easy to 5) Very Difficult. On the other scale this includes 1) Strongly Agree or 2) Agree on a scale ranging from 1) Strongly Agree to 5) Strongly Disagree.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
is male and at least 18 years of age
-
is self-catheterizing at least 3 times a day
-
has been performing catheterizations for at least 2 months
-
wheelchair bound
-
is able to use a size 12 or 14 French straight catheter
-
is willing and able to follow the study protocol and Investigator's instructions
-
is, in the opinion of the Investigator, qualified to participate
Exclusion Criteria:
-
has cognitive impairments that preclude completion of study protocol
-
cannot communicate as determined by the Investigator
-
has an existing medical condition that, in the opinion of the investigator, would interfere with the subject's ability to participate or in the interpretation of the results
-
has a symptomatic urinary tract infection determined by interview
-
has a retracted penis
-
has participated in a study during the previous 30 days involving catheterization
-
has been diagnosed with an enlarged prostate
-
has urethral strictures, false passages, or urethral obstruction
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Shepherd Center and Crawford Research Institute | Atlanta | Georgia | United States | 30309-1465 |
2 | Mark Drug Medical Supply | Wheeling | Illinois | United States | 60090 |
3 | Restored Images | Kansas City | Missouri | United States | 64119 |
4 | Vanderbilt University | Nashville | Tennessee | United States | 37235 |
Sponsors and Collaborators
- Hollister Incorporated
Investigators
- Study Director: Rita Kaurs, MSHSA MT NMT, Hollister Incorporated
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- 4875-I
Study Results
Participant Flow
Recruitment Details | Recruitment period: October 10, 2010 - July 21 , 2011 types of locations: private vendor, public rehabilitation center, university |
---|---|
Pre-assignment Detail |
Arm/Group Title | Control and Test Crossover |
---|---|
Arm/Group Description | test and control intermittent urinary catheters : randomized cross-over |
Period Title: Overall Study | |
STARTED | 91 |
COMPLETED | 82 |
NOT COMPLETED | 9 |
Baseline Characteristics
Arm/Group Title | Control and Test Crossover |
---|---|
Arm/Group Description | test and control intermittent urinary catheters : randomized cross-over |
Overall Participants | 82 |
Age (Count of Participants) | |
<=18 years |
0
0%
|
Between 18 and 65 years |
82
100%
|
>=65 years |
0
0%
|
Age (years) [Mean (Standard Deviation) ] | |
Mean (Standard Deviation) [years] |
38.3
(11.7)
|
Gender (Count of Participants) | |
Female |
0
0%
|
Male |
82
100%
|
Region of Enrollment (participants) [Number] | |
United States |
82
100%
|
Outcome Measures
Title | Percentage of Participants |
---|---|
Description | Percentage of participants that preferred the 40 cm catheter |
Time Frame | 1 week |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Control and Test Crossover |
---|---|
Arm/Group Description | Control and test intermittent urinary catheters : randomized cross-over |
Measure Participants | 82 |
Number [percentage of participants] |
91.5
111.6%
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Control and Test Crossover |
---|---|---|
Comments | The sample size of 81 subjects provides a 10.8% margin of error. | |
Type of Statistical Test | Superiority or Other | |
Comments | ||
Statistical Test of Hypothesis | p-Value | |
Comments | ||
Method | ||
Comments | ||
Method of Estimation | Estimation Parameter | Proportion |
Estimated Value | 91.5 | |
Confidence Interval |
(2-Sided) 95% 84.5 to 97.5 |
|
Parameter Dispersion |
Type: Value: |
|
Estimation Comments | Seventy five of the 82 subjects (91.5%) preferred the longer commercially available catheter over the experimental 30 cm catheter. |
Title | Assessment of Ease of Use Characteristics |
---|---|
Description | Ease of insertion, removal, and control while catheterizing were assessed using a 5 point Likert scale. The numbers recorded are the percentage of the "top" two responses on a 5 point Likert scale. On one scale this includes 1) Very Easy or 2) Easy, on a scale ranging from 1) Very Easy to 5) Very Difficult. On the other scale this includes 1) Strongly Agree or 2) Agree on a scale ranging from 1) Strongly Agree to 5) Strongly Disagree. |
Time Frame | 1 week |
Outcome Measure Data
Analysis Population Description |
---|
82 self-catheterizing wheelchair-using men |
Arm/Group Title | Control 40 cm Catheter | Test 30 cm Catheter |
---|---|---|
Arm/Group Description | Commercial gel lubricated 40 cm catheter | Test gel lubricated 30 cm catheter identical in all aspects to Control catheter except being 10 cm shorter |
Measure Participants | 82 | 82 |
Ease of insertion |
84.65
103.2%
|
67.78
NaN
|
Ease of Removal |
94.85
115.7%
|
86.34
NaN
|
Ease of Catheter Control Upon Urethral Insertion |
86.48
105.5%
|
72.19
NaN
|
Confidence of Complete Bladder Drainage |
84.15
102.6%
|
45.80
NaN
|
Ease of Draining into Receptacle |
87.00
106.1%
|
58.02
NaN
|
Ease of Connecting Urine Bag |
35.68
43.5%
|
31.49
NaN
|
Adverse Events
Time Frame | ||||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Control 40 cm Catheter | Test 30 cm Catheter | ||
Arm/Group Description | Commercial 40 cm gel lubricated catheter | Test 30 cm gel lubricated cather similar in all aspects except 10 cm shorter length as control catheter | ||
All Cause Mortality |
||||
Control 40 cm Catheter | Test 30 cm Catheter | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | ||
Serious Adverse Events |
||||
Control 40 cm Catheter | Test 30 cm Catheter | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/91 (0%) | 0/91 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Control 40 cm Catheter | Test 30 cm Catheter | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/91 (0%) | 2/91 (2.2%) | ||
Renal and urinary disorders | ||||
bleeding | 0/91 (0%) | 0 | 1/91 (1.1%) | 91 |
discomfort | 0/91 (0%) | 0 | 1/91 (1.1%) | 91 |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
Variable restriction depends on site.
Results Point of Contact
Name/Title | Malford Cullum PhD/Sr Clin Res Scientist |
---|---|
Organization | Hollister Incorporated |
Phone | 847-918-3975 |
malford.cullum@hollister.com |
- 4875-I